Pfizer, Starboard Value
Activist investor takes $1B stake in Pfizer, aims to turn around company
Citing people familiar with the matter, The Journal reported that Starboard approached former Pfizer CEO Ian Read and CFO Frank D’Amelio to assist in its plans.
Activist investor Starboard Value takes $1 bln stake in Pfizer, sources say
Activist investor Starboard Value has taken a stake of about $1 billion in Pfizer and wants the U.S. drug giant to make changes to turn its performance around, sources familiar with the matter said on Sunday.
Watch These Pfizer Price Levels as Stock Gains After Report of Starboard Taking Stake
Pfizer shares have gained ground since a report over the weekend said that activist investor Starboard Value has taken a roughly $1 billion stake in the drug maker and is pushing for changes. Monitor these important chart levels.
Activist Starboard Value Takes $1 Billion Stake in Pfizer
Activist investor Starboard Value has taken a stake of about $1 billion in Pfizer Inc. and is seeking to spur a turnaround of the struggling pharmaceuticals giant, according to a person familiar with the matter.
Activist investor Starboard Value takes $1 billion stake in Pfizer, sources say
Activist investor Starboard Value has taken a stake of about $1 billion in Pfizer and wants the U.S. drug giant to make changes to turn its performance around, sources familiar with the matter said on Sunday.
Pfizer Receives $1 Billion From Starboard Value, Stock Rises
Shares of Pfizer PFE rose 2.17% on Oct. 7 after a report from The Wall Street Journal stated that activist investor Starboard Value has taken a roughly $1 billion stake in the company. Investors cheered the news on hopes of a plausible turnaround with this investment.
Starboard Value takes $1 billion stake in Pfizer: Reports
An activist invester has taken interest in pharma giant Pfizer, which despite becoming a household name during the pandemic has struggled to move its stock.
Pfizer shares jump on $1 bln activist investor stake
Activist investor Starboard Value has taken a stake of about $1 billion in Pfizer and wants the U.S. drug giant to make changes to turn its performance around, sources familiar with the matter said. Alex Cohen has more.
What's Happening With Pfizer Stock?
Looking at a slightly longer term, the performance of PFE stock with respect to the index has been quite volatile in recent ...
Pfizer and CVS Are Attracting Activists. Healthcare Stocks Could Rebound.
The smart money seems to be calling a bottom for the healthcare sector. That could mean it’s time for investors to start taking another look at the industry’s more beleaguered stocks. Since the start ...
Amid Pfizer's Struggles With Declining Demand For COVID-19 Treatments, Activist Investor Starboard Value Invests $1B In Pharma Giant: Report
Activist investor Starboard Value has invested approximately $1 billion in Pfizer Inc. This strategic move occurs as the pharmaceutical giant grapples with a downturn in demand for its COVID-19 ...
GSK, Pfizer RSV vaccine sales fall in US as millions fewer people line up
U.S. sales of RSV vaccines from GSK and Pfizer are down significantly after regulators narrowed the targeted age group and ...
Yahoo Finance24d
Is Pfizer's 5.7% Dividend Yield Worth the Risk?
However, Pfizer's payout ratio of 436% raises significant concerns about sustainability. Is Pfizer's high dividend worth the risk? Let's dig deeper to find out. Pfizer is a global ...
Business Insider2d
Starboard Takes $1 Bln Stake In Pfizer, Pushes For Major Changes : Report
This has led to a drop in earnings and share performance, as the company overestimated future pandemic-related demand, the report said. Additionally, Pfizer has faced criticism for a lack of ...
NBC 10 Philadelphia2d
Activist Starboard Value has $1 billion Pfizer stake, taps former executives for help, sources say
The Wall Street Journal earlier reported news of Starboard's stake. A Pfizer spokesperson declined to comment on "speculation and rumor." — CNBC's Angelica Peebles contributed to this report.
pharmaphorum4d
Pfizer cut vaccine production targets because of raw material shortage - reports
Pfizer slashed its production targets for its COVID-19 vaccine because of a lack of raw materials for its supply chain, according to press reports. The big pharma has said in recent weeks that it ...